Recruiting

Observational Study

Sponsor:

Inova Health Care Services

Code:

NCT03378739

Conditions

Cardiogenic Shock

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Cardiogenic Shock team activation

Study Details

Brief summary:

To collect retrospective clinical outcomes related to acute decompensated heart failure cardiogenic shock, acute myocardial infarction cardiogenic shock and compare current versus historical survival rates.

To collect Inova Heart and Vascular Institute (IHVI) site specific outcomes before and after initiation of the Cardiogenic Shock team on January 1, 2017.

To collect outcomes related to implementation of mechanical circulatory support versus no circulatory intervention and type of intervention (extracorporeal membrane oxygenation (ECMO) versus intracorporeal axial-flow (Impella).

• Assess survival at three time points.

Conditions

Cardiogenic Shock

Study ID

NCT03378739

Start date

Jan 1, 2018

Status verified date

Mar, 2026

Completion date

Dec 31, 2099

Anticipated

Primary completion date

Dec 31, 2099

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Inclusion Criteria:

-Patients at the IHVI with documented Cardiogenic Shock team intervention for acute decompensated heart failure cardiogenic shock, or acute myocardial infarction cardiogenic shock.

Exclusion Criteria:

-Patients under the age of 18 will be excluded.

Study Design

Enrollment

3000 participants

Anticipated

Interventions and Outcome Measures

Interventions

Cardiogenic Shock team activation

Any patient with cardiogenic shock, whether inpatient or transferred from another facility, treated at the Inova Heart and Vascular Institute by the designated Cardiogenic Shock Team.

Primary outcome measure

  • Retrospective review of Cardiogenic shock patients outcomes [ Time Frame: 1 Year ]

Central Contacts and Locations

Central contacts

Bhruga Shah

703-776-2828bhruga.shah@inova.org

Locations

Inova Fairfax Hospital

Recruiting

Falls Church, Virginia, United States, 22042

Principal Investigator:

Alex Truesdell, MD

More Information

Sponsor

Inova Health Care Services

Last update posted

Mar 16, 2026

Last verified

Mar, 2026

Keywords

  • cardiogenic
  • shock

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Inova Health Care Services on 2026-03-16.